Carl Zeiss Meditec AG
Company Profile
Business description
Carl Zeiss Meditec is one of the largest medical technology companies in the world, and it operates in two segments: ophthalmic devices and microsurgery. OPT, which made up 75% of sales in 2022, includes refractive lasers, surgical ophthalmic devices, equipment for ophthalmic diagnostics, as well as a portfolio of intraocular lenses and disposable medical instruments. With a low-teens share of the market, Zeiss is the second-largest player in the space. MCS is composed of implants, surgical instruments, and visualization devices used during neurosurgery, spine surgery, and otolaryngology surgery. With over 60% market share, Zeiss is the clear leader in the microsurgery space.
Contact
Goschwitzer Strasse 51-52
JenaTH07745
DEUT: +49 3641220115
Sector
Healthcare
Stock type
Defensive
Industry
Medical Instruments & Supplies
Fiscal Year End
30 September 2025
Employees
5,730
Stocks News & Analysis
stocks
WiseTech result disappoints, but the future looks bright
stocks
WOW earnings: Woolworths losing market share, but will catch up to Coles
stocks
Chart of the Week: Largest share price falls during earnings
Morningstar Investment Ideas
Markets
Index | Last price | Change | % Change |
---|---|---|---|
All Ordinaries | 9,231.20 | 10.40 | -0.11% |
CAC 40 | 7,743.93 | 34.12 | 0.44% |
DAX 40 | 24,046.21 | 106.66 | -0.44% |
Dow JONES (US) | 45,565.23 | 147.16 | 0.32% |
FTSE 100 | 9,255.50 | 10.30 | -0.11% |
HKSE | 25,032.08 | 169.68 | -0.67% |
NASDAQ | 21,590.14 | 45.87 | 0.21% |
Nikkei 225 | 42,790.60 | 270.33 | 0.64% |
NZX 50 Index | 12,920.19 | 58.35 | 0.45% |
S&P 500 | 6,481.40 | 15.46 | 0.24% |
S&P/ASX 200 | 8,969.10 | 1.40 | -0.02% |
SSE Composite Index | 3,803.08 | 2.73 | 0.07% |